Schwab International Equity ETF (SCHF) stock analysis, October 20, 2026: Developed-market basket slips toward its 200-day average

Schwab International Equity ETF (SCHF) trades at $26.85, down about 5% from its September 22, 2026 closing peak of $28.25 and sitting just above its 200-day average at $26.80. The basket is below its 40-week average and has trailed the S&P 500 by 3.3% over 50 days. The balance of evidence leans negative, with medium conviction. A daily close below $26.80 would be the next test of that reading.

Why it matters

No news item from the past few days explains this move. The fund's pullback has no single headline behind it: no holdings change, no flow report and no sector event appears in the record. What the backdrop does show is a slow shift in how international markets trade against the US. A Forbes column argues that synchronized global monetary policy has ended and that economies now follow separate inflation and rate paths. A Bloomberg newsletter described French and German yields at 18- and 15-year highs and the yen weakening past 155 per dollar. Rising yields and a falling yen are the kind of pressure that can weigh on a basket of developed-market shares outside the US.

The market had already priced in much of the weakness by the time this week began. The fund has slipped from the September peak in an orderly way, with an oversold-leaning RSI of 34 rather than a collapse. Over five days SCHF fell 1.1% against 1.5% for SPY, so this week's drop was mostly the broad market and the fund fell slightly less. The longer comparison is less kind: over one month the fund is down 3.2% while SPY is up 0.6%. Year to date SCHF is up 11.7% against 12.4% for SPY, so most of the year's gap opened recently. No sector benchmark is available for the basket, so the split is between the market and the fund itself, and the fund's own drift since late September is the larger part of the story.

The argument over international equities runs both ways. The bullish case is valuation: Morningstar's September 22 piece picked three wide-moat international names trading below fair value, including AstraZeneca at a $184 per ADR estimate, and made the case that foreign stocks are cheap relative to quality. A separate Morningstar article pointed to energy and natural resources outperforming, with XLE up 47% against 13% for the S&P 500 as oil broke $100. That helps the parts of a developed-market basket tied to commodities. The bearish case is the one in the price: the same yield and currency pressure that makes the divergence story interesting also makes it a headwind. Those articles speak to individual stocks and themes rather than to SCHF as a whole, and none puts a price target on the fund. There is no analyst target or consensus to measure the fund against.

What the evidence says

For the long term, the thesis of steady international gains is weakened but not broken. Price is below the 40-week average, so the weekly trend is down. The fund is still 16.9% above its 52-week low of $22.96 and 6.1% below its high of $28.59, and the six-month gain is only 0.3%. That describes a basket that has gone sideways for half a year and is now rolling over from the upper part of its range, not one that has collapsed.

For the next 2–6 weeks the balance of evidence leans negative, with medium conviction, 2 points out of 4. Two things carry the reading: the daily trend runs with the weekly downtrend, and the fund has lagged the S&P 500 by 3.3% over 50 days. The 50-day average at $27.86 sits well above the price and acts as a ceiling. The conviction is not higher because only half the checks line up.

The strongest case against is that the fall is already stretched. The RSI of 34 is close to oversold. The fund fell less than SPY over five days. The 200-day average at $26.80 is directly under the price and has not yet given way. A bounce from there toward $27.10 would not be surprising. That does not tip the balance, because a bounce into overhead resistance would still leave the weekly trend pointing down, and it is the reason conviction stops at medium.

Levels that matter

In a downtrend the structure holds below $27.10, where sellers have appeared on earlier rallies. The weekly trend would end above $27.68, another swing zone, with the 50-day average at $27.86 just above it. Resistance then stacks up through $28.20 and the 52-week high at $28.59. Below the price, the first support is the 200-day average at $26.80, then $26.68, then the round $25.00.

The breakout level is a daily close below $26.80, the 200-day average. From there the first target is $26.68, and the math gives only 0.3 to 1 against a stop at $27.17, which is $27.10 plus a quarter of the 14-day ATR of $0.28. The second target is the 52-week low at $22.96, which gives 10.4 to 1. The 3-to-1 threshold is met, but only because of that far target. The near target alone does not come close, and it is a long way from $26.80 to $22.96, with $25.00 in between.

What would change the picture

A weekly close above $27.68 would change the picture, because it would put the fund back above the level where the weekly downtrend ends. The non-price fact that would most likely do it is evidence that the pressure on European yields and the yen is easing, or visible money flowing back into international funds. That would turn the divergence story from a headwind into a tailwind for the basket.

What to watch

• The daily close against $26.80, the 200-day average, and then $26.68.
• The $27.10 and $27.68 levels, and the 50-day average at $27.86, as the ceiling on any bounce.
• Whether the 50-day gap to the S&P 500, now -3.3%, narrows or widens. The gap over 200 days is -5.1%.
• European bond yields and the yen near 155 per dollar, the two pressure points in the backdrop. No dated releases are listed in the data.
• Fund flows and holdings changes. None are reported in the current news, so a change would be new information.